These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Prospects in the phthisiological field]. RABINO A Minerva Med; 1957 Sep; 48(76):3016-20. PubMed ID: 13483321 [No Abstract] [Full Text] [Related]
45. [A clinical experience report on combined therapy of pulmonary tuberculosis with cycloserine-pyrazinamide]. BUTT H Wien Med Wochenschr; 1961 Jan; 111():57-61. PubMed ID: 13689455 [No Abstract] [Full Text] [Related]
46. [Studies on the treatment of pulmonary tuberculosis with cycloserine. IV. Clinical results and conclusions]. de ALEMQUER ; BOTO V J Med (Oporto); 1960 Oct; 43():163-70. PubMed ID: 13682283 [No Abstract] [Full Text] [Related]
47. Relation of plasma levels of cycloserine to oral dosage and clinical response in pulmonary tuberculosis. EPSTEIN IG; NAIR KG; ENCARNACION B; MULINOS MG Sea View Hosp Bull; 1960 Jul; 18():44-52. PubMed ID: 13697014 [No Abstract] [Full Text] [Related]
48. [Cycloserine associated with other chemio-antibiotics in the treatment of pulmonary tuberculosis. Clinical contribution on pyrazinamidecycloserine association]. SACCO F; GUALA B; GUERRA P Minerva Med; 1961 Jan; 52():139-44. PubMed ID: 13745206 [No Abstract] [Full Text] [Related]
49. [Clinical experience with cycloserine in pulmonary tuberculosis]. KOSTER E Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1957; 117(2):317-26. PubMed ID: 13522546 [No Abstract] [Full Text] [Related]